GlassScriptPhysician profile
Clinton R Collins
NPI 1275568651
$1,385.29
in general payments reported to CMS, 2019-2025
15 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $141 · 2021: $99.10 · 2022: $21.67 · 2023: $77.98 · 2024: $197 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $660.06 | 2019-2025 | Epclusa |
| Glaxosmithkline, LLC. | $128.49 | 2019-2023 | Shingrix |
| Pfizer INC. | $117.19 | 2019 | |
| Vanda Pharmaceuticals INC. | $105.88 | 2025 | Fanapt |
| Astellas Pharma US INC | $78.90 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $70.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.09 | 2019 | |
| Novo Nordisk INC | $38.21 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.47 | 2019 | |
| Abbvie INC. | $24.94 | 2024 | |
| Abbott Laboratories | $21.67 | 2022 | |
| Bausch Health US, LLC | $19.78 | 2019 | |
| Sanofi Pasteur INC. | $17.65 | 2019 | |
| Mannkind Corporation | $17.39 | 2019 | |
| Nevro Corp. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.